Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03184077 · ClinicalTrials.gov registry record · NA
Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 318
- Enrollment target
NCT03184077 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 318 participants.
The verdict
NCT03184077, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 318 participants
- Enrollment target
Study Summary
To evaluate the rates of dyspareunia with rapidly absorbing polyglactin 910 compared to poliglecaprone 25 using a validated sexual function questionnaire. To assess maternal satisfaction with the laceration repair and suture material. To assess overall perineal pain using a visual analog scale. To assess the rate of wound breakdown and the need for suture removal.
Interventions
- PROCEDURE Laceration Repair with Polyglactin 910
- PROCEDURE Laceration Repair with poliglecaprone 25
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2014-09-02 |
| Est. Completion | 2017-08-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03184077
The ClinicalTrials.gov registry entry for NCT03184077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laceration Repair with Polyglactin 910 is the first listed.
NCT03184077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03184077 about?
NCT03184077 is a clinical study titled "Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair". To evaluate the rates of dyspareunia with rapidly absorbing polyglactin 910 compared to poliglecaprone 25 using a validated sexual function questionnaire. To assess maternal satisfaction with the laceration repair and suture material. To assess overall perineal pain using a visual analog scale. T...
What is the current status of trial NCT03184077?
This trial is currently completed. It is a NA study. The enrollment target is 318 participants. The study started on 2014-09-02. Estimated completion is 2017-08-27.
What interventions are being tested in trial NCT03184077?
The interventions under investigation include: Laceration Repair with Polyglactin 910 (PROCEDURE), Laceration Repair with poliglecaprone 25 (PROCEDURE).
Who is sponsoring clinical trial NCT03184077?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.